Fig. 1

Changes of Factor and total scores in type 1 and type 2 diabetes mellitus. The upper figure (a) showed the type 1, the lower figure (b) shows the type 2 patients after switching from glargine or detemir to degludec. Grey, white, and dark columns indicate scores at baseline, 12 weeks, and 24 weeks, respectively. Data are mean ± SD (bars) for all assigned participants. Comparisons were made by ANOVA. ^* p < 0.05, ^** p < 0.005, significantly different from baseline